Our Values and Quality Policy

Nano4 Global

Nano4 Global is a young start-up launched in 2015 to market innovative nanotechnology based molecular diagnostics.


In vitro molecular diagnosis is at the core of our activity. We develop simple and rapid point-of-need molecular diagnostics, promoting the patient access to medical care, regardless of condition or geography. 


NANO4 Global provides products within the highest standards of quality, efficacy and safety, that can improve health care standards by converting molecular diagnostics into fast and simple systems globally accessible, addressing unmet medical needs. 


Innovation | Entrepreneurship | Collaboration | Solidarity | Motivation | Integrity 

Guiding Principles of Quality Policies

  • That scientific and medical community is constantly and correctly informed about the technological advances related to the diagnostics of pathologies upon which the company is focused.
  • User satisfaction.
  • That the company's internal regulations are transposed to the daily management.

  • Rapid and point-of-need diagnostic needs.
  • User needs.

  • Commitment to suppliers.
  • Commitment to shareholders.

  • Adequate availability of products and services in timely manner.
  • The development and constant updating NANO4 human resources to guarantee high standard of quality on the developed activity.
  • The existence of necessary resources to develop the defined strategies so that mission is fulfilled.
  • Policy, mission, values and strategy of NANO4 have a positive impact in assisting the practice of clinical diagnosis and make an important contribution to society in general.

Back to homepage


News & Updates
  July  2021
NANO4 in partnership with CUF Hospitals and Clinics network initiates validation of diagnostics platform for Chronic Myeloid Leukaemia
  November  2019
NANO4 was recognized with the NOVA SPIN-OFF seal